Analyst Ratings for Opexa Therapeutics (OPXA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2011 | Chardan Capital | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
2.01 (1.06) |
-47.26% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2011 | Chardan Capital | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
2.01 (1.06) |
-47.26% | Details |
